TRIM63 and sarcoma: In summary, TRIM63 RNA-ISH may be useful in challenging cases, not necessarily as a replacement for broad sarcoma-specific molecular panels, but as a cost-effective adjunct stain in cases for which ASPS is one of several differential considerations, allowing for more efficient selection of cases for ancillary molecular testing.